SpeechPathology.com Phone: 800-242-5183


The Stepping Stones Group Summer - July 2024

What is Sickle Cell Disease?

Candice J. Adams-Mitchell, SLP.D, CCC-SLP

March 15, 2023

Share:

Question

What is sickle cell disease?

Answer

Sickle cell disease is a group of inherited red blood cell disorders affecting millions of individuals throughout the world. The CDC estimates that approximately 300,000 people worldwide have sickle cell disease, with about 100,000 in the United States. Sickle cell disease is associated with an increased risk of early death and has adverse clinical complications impacting various organ systems. In turn, patients with sickle cell disease and their families report significantly diminished quality of life from childhood to adulthood. 

Understanding the different variants of sickle cell disease is important. If you are treating a patient at a hospital or in a school setting, it is important to understand what they might be experiencing based on their variant of sickle cell disease and how that may impact clinical treatment.

There are several types of sickle cell disease. The most common ones are:

  • Hemoglobin SS (Sickle cell anemia)
  • Hemoglobin SC (Sickle C disease)
  • Hemoglobin SB + (Sickle beta thalassemia)
  • Hemoglobin SB 0 (Sickle beta zero thalassemia)
  • Hemoglobin SD, SE, SO (Sickle D, E, or O disease)

Sickle cell anemia, type SS, occurs when a child inherits one substitution beta-globin gene, the sickle gene, from both parents. This child has what is commonly called sickle cell anemia. Populations with a high frequency of sickle cell anemia are of African and Indian descent. This is considered the most severe type of sickle cell disease because the person has both SS genes. They experience severe anemia and severe pain because most of the red blood cells in their body are sickle-shaped. 

The next variant is Hemoglobin SC. These are individuals with sickle hemoglobin C. They have a slightly different substitution in their beta-globin gene that produces both hemoglobin C and hemoglobin S. Sickle hemoglobin C disease may cause similar symptoms as sickle cell anemia but because they don't have both SS genes, there is less anemia. Populations with a high frequency of sickle hemoglobin C disease are those of West African, Mediterranean, and Middle Eastern descent.

Individuals with sickle beta thalassemia disease, both + and 0, have substitutions in both beta-globin genes. The severity of this disease will vary in patients according to the amount of normal beta-globin they can produce. When no beta-globin is produced, these patients' symptoms will be identical to sickle cell anemia, with the most severe cases needing chronic blood transfusions. Populations with a high frequency of sickle beta thalassemia are of Mediterranean and Caribbean descent.

Sickle hemoglobin O disease is another substitution in the beta-globin gene that interacts with sickle hemoglobin. Why is that important? Because even if you don't have the sickle trait but have hemoglobin O and you have a child with someone who does have the sickle trait, the hemoglobin O interacts with that sickle hemoglobin. So, individuals with sickle hemoglobin O have similar symptoms of sickle cell anemia. Populations with a high frequency of sickle hemoglobin O disease are of Arabian, North African, and Eastern Mediterranean descent.

With sickle hemoglobin D disease, a different substitution of the beta-globin gene has been found to interact with the sickle hemoglobin gene. Individuals with sickle hemoglobin D have moderately severe anemia and occasional pain episodes. Populations with a high frequency of sickle hemoglobin D are those of Asian and Latin American descent.

This ATE is an excerpt from the course Sickle Cell Disease Management: The Role of SLPs and Audiologists, Part 1, presented by Candice J. Adams-Mitchell, SLP.D, CCC-SLP.


candice j adams mitchell

Candice J. Adams-Mitchell, SLP.D, CCC-SLP

Dr. Candice Adams-Mitchell is a Clinical Assistant Professor at the University of Florida. Her research focuses on neurological manifestations of sickle cell disease. Additional research interest includes concussion assessment and management, improving patient health literacy, and reducing neuropsychological disparities in culturally diverse and/or historically disadvantaged populations. She has clinical experience working in SNFs, hospitals, schools, and home health.


Related Courses

Sickle Cell Disease Management: The Role of SLPs and Audiologists, Part 2
Presented by Candice J. Adams-Mitchell, SLP.D, CCC-SLP
Video

Presenter

Candice J. Adams-Mitchell, SLP.D, CCC-SLP
Course: #10265Level: Introductory1 Hour
  'Great information on Sickle Cell Disease Management'   Read Reviews
This Part 2 of a two-part series focuses on the role of SLPs and audiologists in treating individuals with Sickle Cell Disease (SCD) and identifies potential barriers to these individuals receiving our services. Current research related to hearing, cognition, and language impairment in SCD is also reviewed.

Sickle Cell Disease Management: The Role of SLPs and Audiologists, Part 1
Presented by Candice J. Adams-Mitchell, SLP.D, CCC-SLP
Video

Presenter

Candice J. Adams-Mitchell, SLP.D, CCC-SLP
Course: #10217Level: Introductory1 Hour
  'Good information to have!'   Read Reviews
This is Part 1 of a two-part series. Research is limited regarding the implications of Sickle Cell Disease (SCD) for communication, with most research dating back to the 1990s and early 2000s. The types of SCD, as well as the neurological manifestations and the pathological changes that produce them are discussed in this course. The role of speech-language pathologists and audiologists in the treatment of these patients is also addressed.

Back to Basics: Down Syndrome
Presented by Theresa Bartolotta, PhD, CCC-SLP
Video

Presenter

Theresa Bartolotta, PhD, CCC-SLP
Course: #8975Level: Introductory1 Hour
  'I found the information useful, and it helped me clarify the results of an evaluation I am currently conducting on a student with Down syndrome'   Read Reviews
This course serves as a primer on Down syndrome for practicing speech-language pathologists. The basics of the syndrome and common speech, language, voice, and fluency issues are addressed. Effective treatment strategies for improving communication across the lifespan are discussed.

Recognizing Fetal Alcohol Spectrum Disorders (FASD) to Improve Outcomes
Presented by Dan Dubovsky, MSW, FASD Specialist
Video

Presenter

Dan Dubovsky, MSW, FASD Specialist
Course: #8724Level: Intermediate1 Hour
  'Great topic! Was able to share lots of information in a short amount of time'   Read Reviews
This course will provide information on the importance of identifying individuals who may have a fetal alcohol spectrum disorder. It will examine how the brain damage from prenatal alcohol exposure affects one's behavior, and best approaches for working with individuals with FASD and their families.

20Q: Becoming a Medical SLP: From NICUs to SNFs and Everything in Between
Presented by Kristie A. Spencer, PhD, CCC-SLP, Jacqueline Daniels, MA, CCC-SLP, Tamar Nir, MA, CCC-SLP
Text

Presenters

Kristie A. Spencer, PhD, CCC-SLPJacqueline Daniels, MA, CCC-SLPTamar Nir, MA, CCC-SLP
Course: #10005Level: Intermediate1 Hour
  'I learned about the many settings/responsibilities of a medical slp'   Read Reviews
This course provides an introduction to the career of a Medical Speech-Language Pathologist, including the wide range of possible employment settings, interdisciplinary colleagues, and clinical caseload considerations. It discusses the recommended initial foundational coursework and preparatory training for beginner to advanced certifications, and clinical specializations for current, practicing SLPs.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.